Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Offering hepatitis C treatment at the point of diagnosis streamlines care, saving both time and money.
Hepatitis C prevalence was higher among people with unstable housing and those who injected drugs every day.
Modern antivirals can cure 95% of people with HCV, lowering the risk of cirrhosis, liver cancer and liver failure.
Older people, men and people living in poverty and lacking private insurance were more likely to have active HCV infection.
The CDC estimates that 21% of people living with HIV also have hepatitis C virus.
Hepatitis A and B declined in 2021, but new hepatitis C cases have doubled since 2014.
About 40% of people worldwide are not aware that viral hepatitis is a leading cause of liver cancer.
Viral hepatitis could kill more people than malaria, tuberculosis and HIV combined if trends continue.
Testing a single blood sample for HCV antibodies and HCV RNA can identify more people who need treatment.
A “jarringly low” proportion of people with HCV have been tested, treated and cured.
Greater political will and financial support for national programs are needed to eliminate viral hepatitis.
Left untreated, hepatitis C can lead to cirrhosis, liver cancer and the need for a liver transplant.
Universal HCV testing led to an increase in the number of pregnant women and infants diagnosed in a timely manner.
Men and Black people were more likely to have antibodies against hepatitis C virus.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.